Synopsis: Dr. Reddy’s Laboratories Ltd. on Monday introduced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot…
Injection
-
-
Biocon PharmaceuticalCompaniesGlobal Market
Biocon Biologics set to reap Biosimilar Insulin Glargine Opportunity in US
by adminby adminSummary : Drugmaker is banking on the ramp-up of interchangeable biosimilar insulin glargine expecting the product to boost the revenue and profit…
-
Summary – Gland Pharma Limited has recently received a tentative approval from the United States Food and Drug Administration (USFDA) for Cangrelor…
-
Nelarabine
Zydus Cadila receives USFDA Final Approval for Nelarabine Injection a Therapeutically Generic Version of Arranon injection.
by adminby adminKEYPOINTS: Zydus Cadila has received final approval from the US FDA to market Nelarabine injection 250MG/50ML in the United States. Zydus Pharmaceuticals…
-
Active Pharmaceutical Ingredients (API)Risankizumab
European Commission approves AbbVie’s Skyrizi (Risankizumab) to Treat Adults with Active Psoriatic Arthritis.
by adminby adminKEYPOINTS: AbbVie announces that the European Commission (EC) has approved SKYRIZI (Risankizumab, 150 mg, subcutaneous injection at week 0, week 4, and…
-
Active Pharmaceutical Ingredients (API)carmustine
Dr. Reddy’s Labs launches Carmustine for Injection Therapeutic Generic version BiCNU in US market.
by adminby adminKeypoints: Reddy’s Laboratories Ltd. has recently announced the launch of Carmustine for Injection, USP. Carmustine, sold under the brand name BiCNU among…